Treatment of selected pharmaceuticals by ferrate(VI): Performance, kinetic studies and identification of oxidation products

Zhengwei Zhou; Jia-Qian Jiang

doi:10.1016/j.jpba.2014.06.032

Treatment of selected pharmaceuticals by ferrate(VI): Performance, kinetic studies and identification of oxidation products

Zhengwei Zhou, Jia-Qian Jiang

Civil Engineering and Environmental Management

Research output: Contribution to journal › Article

108 Downloads (Pure)

Abstract

The performance of ferrate(VI) in treating sulfamethoxazole (SMX), diclofenac (DCF), carbamazepine (CBZ) and bezafibrate (BZF) in test solutions containing the four compounds was investigated. A series of jar-test experiments was performed on a bench-scale at pH 6–9 and at a ferrate(VI) dose of 1–5 mg Fe/L. The results suggested that ferrate(VI) can effectively remove SMX, DCF and CBZ from the test solutions, with greater than 80% removal under optimum conditions. However, the removal efficiency of BZF was very low, less than 25% under the studied conditions. Increasing the dose of ferrate(VI) improved the treatment performance, while the influence of solution pH on ferrate(VI) performance varied among the different target compounds.

Original language	English
Pages (from-to)	37-45
Number of pages	9
Journal	Journal of Pharmaceutical and Biomedical Analysis
Volume	106
Early online date	1 Jul 2014
DOIs	https://doi.org/10.1016/j.jpba.2014.06.032
Publication status	Published - Mar 2015

Keywords

water treatment
ferrate (VI)

Documents and Links

10.1016/j.jpba.2014.06.032

Zhou, Z & Jiang, J-Q (2015) Journal of Pharmaceutical and Biomedical Analysis article
This is the author final version of an article published in Journal of Pharmaceutical & Biomedical Analysis (2015). The publisher version of the article is available via the DOI link below. Published by Elsevier, copyright © 2016 Elsevier B.V.
Accepted author manuscript, 597 KB

Fingerprint Dive into the research topics of 'Treatment of selected pharmaceuticals by ferrate(VI): Performance, kinetic studies and identification of oxidation products'. Together they form a unique fingerprint.

Cite this

Zhou, Z., & Jiang, J-Q. (2015). Treatment of selected pharmaceuticals by ferrate(VI): Performance, kinetic studies and identification of oxidation products. Journal of Pharmaceutical and Biomedical Analysis, 106, 37-45. https://doi.org/10.1016/j.jpba.2014.06.032

@article{e88071ddf32f49699c35136ead698f70,

title = "Treatment of selected pharmaceuticals by ferrate(VI): Performance, kinetic studies and identification of oxidation products",

abstract = "The performance of ferrate(VI) in treating sulfamethoxazole (SMX), diclofenac (DCF), carbamazepine (CBZ) and bezafibrate (BZF) in test solutions containing the four compounds was investigated. A series of jar-test experiments was performed on a bench-scale at pH 6–9 and at a ferrate(VI) dose of 1–5 mg Fe/L. The results suggested that ferrate(VI) can effectively remove SMX, DCF and CBZ from the test solutions, with greater than 80% removal under optimum conditions. However, the removal efficiency of BZF was very low, less than 25% under the studied conditions. Increasing the dose of ferrate(VI) improved the treatment performance, while the influence of solution pH on ferrate(VI) performance varied among the different target compounds. ",

keywords = "water treatment, ferrate (VI)",

author = "Zhengwei Zhou and Jia-Qian Jiang",

year = "2015",

month = mar,

doi = "10.1016/j.jpba.2014.06.032",

language = "English",

volume = "106",

pages = "37--45",

journal = "Journal of Pharmaceutical and Biomedical Analysis",

issn = "0731-7085",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Treatment of selected pharmaceuticals by ferrate(VI): Performance, kinetic studies and identification of oxidation products

AU - Zhou, Zhengwei

AU - Jiang, Jia-Qian

PY - 2015/3

Y1 - 2015/3

N2 - The performance of ferrate(VI) in treating sulfamethoxazole (SMX), diclofenac (DCF), carbamazepine (CBZ) and bezafibrate (BZF) in test solutions containing the four compounds was investigated. A series of jar-test experiments was performed on a bench-scale at pH 6–9 and at a ferrate(VI) dose of 1–5 mg Fe/L. The results suggested that ferrate(VI) can effectively remove SMX, DCF and CBZ from the test solutions, with greater than 80% removal under optimum conditions. However, the removal efficiency of BZF was very low, less than 25% under the studied conditions. Increasing the dose of ferrate(VI) improved the treatment performance, while the influence of solution pH on ferrate(VI) performance varied among the different target compounds.

AB - The performance of ferrate(VI) in treating sulfamethoxazole (SMX), diclofenac (DCF), carbamazepine (CBZ) and bezafibrate (BZF) in test solutions containing the four compounds was investigated. A series of jar-test experiments was performed on a bench-scale at pH 6–9 and at a ferrate(VI) dose of 1–5 mg Fe/L. The results suggested that ferrate(VI) can effectively remove SMX, DCF and CBZ from the test solutions, with greater than 80% removal under optimum conditions. However, the removal efficiency of BZF was very low, less than 25% under the studied conditions. Increasing the dose of ferrate(VI) improved the treatment performance, while the influence of solution pH on ferrate(VI) performance varied among the different target compounds.

KW - water treatment

KW - ferrate (VI)

U2 - 10.1016/j.jpba.2014.06.032

DO - 10.1016/j.jpba.2014.06.032

M3 - Article

VL - 106

SP - 37

EP - 45

JO - Journal of Pharmaceutical and Biomedical Analysis

JF - Journal of Pharmaceutical and Biomedical Analysis

SN - 0731-7085

ER -